Skip to main content

and
  1. Article

    Open Access

    A prospective cohort study about the effect of repeated living high and working higher on cerebral autoregulation in unacclimatized lowlanders

    Cerebral autoregulation (CA) is impaired during acute high-altitude (HA) exposure, however, effects of temporarily living high and working higher on CA require further investigation. In 18 healthy lowlanders (...

    Laura C. Graf, Sara E. Hartmann, Mona Lichtblau, Lara Muralt in Scientific Reports (2022)

  2. Article

    Open Access

    Effect of nocturnal oxygen therapy on exercise performance of COPD patients at 2048 m: data from a randomized clinical trial

    This trial evaluates whether nocturnal oxygen therapy (NOT) during a stay at 2048 m improves altitude-induced exercise intolerance in lowlanders with chronic obstructive pulmonary disease (COPD). 32 lowlanders...

    Sophia Gutweniger, Tsogyal D. Latshang, Sayaka S. Aeschbacher in Scientific Reports (2021)

  3. No Access

    Article

    Physical activity in incident patients with pulmonary arterial and chronic thromboembolic hypertension

    The cardinal symptom of pulmonary hypertension (PH) is dyspnea on exertion, leading to decreased activity in daily living. The aim of this study was to analyze daily physical activity in incident patients with...

    Stéphanie Saxer, Mona Lichtblau, Charlotte Berlier, Elisabeth D. Hasler in Lung (2019)

  4. Article

    Open Access

    Asthma rehabilitation at high vs. low altitude: randomized parallel-group trial

    To investigate the effect of asthma rehabilitation at high altitude (3100 m, HA) compared to low altitude (760 m, LA).

    Stéphanie Saxer, Simon R. Schneider, Paula Appenzeller in BMC Pulmonary Medicine (2019)

  5. No Access

    Article

    Real-Life Experience with Selexipag as an Add-On Therapy to Oral Combination Therapy in Patients with Pulmonary Arterial or Distal Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Analysis

    Patients with pulmonary arterial hypertension (PAH) and distal chronic thromboembolic pulmonary hypertension (CTEPH) who still reveal risk factors of worse prognosis on double combination therapy may benefit f...

    Charlotte Berlier, Esther I. Schwarz, Stéphanie Saxer, Mona Lichtblau in Lung (2019)

  6. No Access

    Article

    Safety and Long-Term Efficacy of Transition from Sildenafil to Tadalafil due to Side Effects in Patients with Pulmonary Arterial Hypertension

    Two phosphodiesterase-type 5 (PDE-5) inhibitors, sildenafil and tadalafil, are approved for treatment of pulmonary arterial hypertension (PAH). It has not yet been observed if transition from sildenafil to tad...

    Mona Lichtblau, Dominik Harzheim, Nicola Ehlken, Alberto Marra, Fabiola Pena Pinado in Lung (2015)

  7. Article

    Open Access

    Exercise training in pulmonary arterial hypertension associated with connective tissue diseases

    The objective of this prospective study was to assess short- and long-term efficacy of exercise training (ET) as add-on to medical therapy in patients with connective tissue disease-associated pulmonary arteri...

    Ekkehard Grünig, Felicitas Maier, Nicola Ehlken in Arthritis Research & Therapy (2012)